AnaptysBio, Inc. ANAB Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $234.6M+157% | $91.28M+432% | $17.16M+66.8% | $10.29M-83.7% | ||
| $135.97M-17.0% | $163.84M+23.9% | $132.28M+49.0% | $88.8M-9.8% | ||
| $50.74M+19.7% | $42.39M+1.1% | $41.95M+14.5% | $36.64M+70.5% | ||
| $186.71M-9.5% | $206.23M+13.6% | $181.57M+44.7% | $125.44M+4.5% | ||
| $186.71M-9.5% | $206.23M+13.6% | $181.57M+44.7% | $125.44M+4.5% | ||
| $47.9M+142% | -$114.95M+30.1% | -$164.41M-42.8% | -$115.15M-103% | ||
| 20.4%+146pp | -125.9%+832pp | -958.3%+161pp | -1,119.4%-1,029pp | ||
| $13.5M-31.8% | $19.79M+4.9% | $18.87M+150% | $7.55M+1,652% | ||
| -$60.96M-101% | -$30.28M— | —— | -$13.55M-1,279% | ||
| —— | -$145.23M+11.2% | -$163.62M-27.1% | -$128.7M-123% | ||
| $164K— | —— | —— | $24K— | ||
| —— | -$145.23M+11.2% | -$163.62M-27.1% | -$128.72M-123% | ||
| —— | -$5.15+15.3% | -$6.08-33.0% | -$4.57-117% | ||
| —— | -$5.15+15.3% | -$6.08-33.0% | -$4.57-117% | ||
| 117.2M+5.2% | 111.4M+3.1% | 108.1M-3.8% | 112.4M+2.5% | ||
| 116M+4.1% | 111.4M+3.1% | 108.1M-3.8% | 112.4M+2.5% | ||
| $79.89M+59.5% | $50.09M+177% | $18.08M-14.3% | $21.11M+1,356% | ||
| —— | -$144.13M+9.4% | -$159.17M-19.2% | -$133.55M-129% | ||
| $13.5M-31.8% | $19.79M+4.9% | $18.87M+150% | $7.55M+1,652% | ||
| -$329K— | —— | $4.45M— | —— | ||
| $5.43M+38,707% | $14K+800% | -$2K— | —— | ||
| $0— | $0-100% | $7.34M— | $0— | ||
| —— | $163.84M+23.9% | $132.28M+49.0% | $88.8M-9.8% | ||
| $234.6M+157% | $91.28M+432% | $17.16M+66.8% | $10.29M-83.7% | ||
| $47.9M+142% | -$114.95M+30.1% | -$164.41M-42.8% | -$115.15M-103% | ||
| $48.46M+142% | -$114.34M+30.2% | -$163.76M-43.0% | -$114.48M-104% | ||
| $48.46M+142% | -$114.34M+30.2% | -$163.76M-43.0% | -$114.48M-104% | ||
| 20.7%+146pp | -125.3%+829pp | -954.5%+158pp | -1,112.9%-1,024pp | ||
| $47.9M+142% | -$114.95M+30.1% | -$164.41M-42.8% | -$115.15M-103% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does AnaptysBio, Inc.'s income statement data come from?
- Every line is extracted from AnaptysBio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.